About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Ppargtm1.1(tTA)Jmgr
targeted mutation 1.1, Jonathan M Graff
MGI:5300919
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0 		involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5581951
cn2
 		Ctnnb1tm2Kem/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0 		involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5581952
cn3
 		Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
Tg(tetO-HIST1H2BJ/GFP)47Efu/0 		involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 MGI:5581950
cn4
 		Ctnnb1tm1Mmt/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0 		involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 MGI:5581956


Genotype
MGI:5581951
cn1
Allelic
Composition		 Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnnb1tm2Kem mutation (1 available); any Ctnnb1 mutation (51 available)
Ppargtm1.1(tTA)Jmgr mutation (1 available); any Pparg mutation (42 available)
Tg(tetO-cre)1Jaw mutation (7 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
skeleton
skeleton phenotype ( J:178340 )
N
• mice exhibit normal bone formation and osteoblast surface/numbers
abnormal osteoclast physiology ( J:178340 )
• decreased proliferation of osteoclast precursors
increased bone volume ( J:178340 )
• at 6 months
abnormal trabecular bone morphology ( J:178340 )
• more trabecular bone and bone surface at 6 months
increased bone trabecula number ( J:178340 )
• with reduced spacing at 6 months

hematopoietic system
abnormal osteoclast physiology ( J:178340 )
• decreased proliferation of osteoclast precursors

immune system
abnormal osteoclast physiology ( J:178340 )
• decreased proliferation of osteoclast precursors




Genotype
MGI:5581952
cn2
Allelic
Composition		 Ctnnb1tm2Kem/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnnb1tm2Kem mutation (1 available); any Ctnnb1 mutation (51 available)
Ppargtm1.1(tTA)Jmgr mutation (1 available); any Pparg mutation (42 available)
Tg(tetO-cre)1Jaw mutation (7 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
skeleton
skeleton phenotype ( J:178340 )
N
• doxycycline-treated mice exhibit normal numbers of osteoblasts, bone formation and bone mineral apposition rates
increased osteoclast cell number ( J:178340 )
• in doxycycline-treated mice
abnormal osteoclast physiology ( J:178340 )
• doxycycline-treated bone marrow cultures exhibit reduced osteoclast precursor proliferation compared with control cultures
abnormal trabecular bone morphology ( J:178340 )
• decreased bone surface in doxycycline-treated mice
decreased trabecular bone volume ( J:178340 )
• trabecular, cortical and total in doxycycline-treated mice
decreased bone trabecula number ( J:178340 )
• with increased spacing in doxycycline-treated mice
decreased trabecular bone mass ( J:178340 )
• in doxycycline-treated mice
decreased trabecular bone thickness ( J:178340 )
• in doxycycline-treated mice
osteoporosis ( J:178340 )
• in doxycycline-treated mice
increased bone resorption ( J:178340 )
• in doxycycline-treated mice

hematopoietic system
increased osteoclast cell number ( J:178340 )
• in doxycycline-treated mice
abnormal osteoclast physiology ( J:178340 )
• doxycycline-treated bone marrow cultures exhibit reduced osteoclast precursor proliferation compared with control cultures

immune system
increased osteoclast cell number ( J:178340 )
• in doxycycline-treated mice
abnormal osteoclast physiology ( J:178340 )
• doxycycline-treated bone marrow cultures exhibit reduced osteoclast precursor proliferation compared with control cultures




Genotype
MGI:5581950
cn3
Allelic
Composition		 Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
Tg(tetO-HIST1H2BJ/GFP)47Efu/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnnb1tm2Kem mutation (1 available); any Ctnnb1 mutation (51 available)
Ppargtm1.1(tTA)Jmgr mutation (1 available); any Pparg mutation (42 available)
Tg(tetO-cre)1Jaw mutation (7 available)
Tg(tetO-HIST1H2BJ/GFP)47Efu mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
skeleton
abnormal osteoclast differentiation ( J:178340 )
• cultured bone marrow cells contain fewer osteoclast precursors compared with control mice

hematopoietic system
abnormal osteoclast differentiation ( J:178340 )
• cultured bone marrow cells contain fewer osteoclast precursors compared with control mice

cellular
abnormal osteoclast differentiation ( J:178340 )
• cultured bone marrow cells contain fewer osteoclast precursors compared with control mice

immune system
abnormal osteoclast differentiation ( J:178340 )
• cultured bone marrow cells contain fewer osteoclast precursors compared with control mice




Genotype
MGI:5581956
cn4
Allelic
Composition		 Ctnnb1tm1Mmt/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
Genetic
Background		 involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnnb1tm1Mmt mutation (0 available); any Ctnnb1 mutation (51 available)
Ppargtm1.1(tTA)Jmgr mutation (1 available); any Pparg mutation (42 available)
Tg(tetO-cre)1Jaw mutation (7 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
skeleton
skeleton phenotype ( J:178340 )
N
• doxycycline-treated mice exhibit normal bone formation and numbers of osteoblasts
abnormal osteoclast differentiation ( J:178340 )
• impaired in doxycycline-treated mice
decreased osteoclast cell number ( J:178340 )
• in doxycycline-treated mice
increased bone volume ( J:178340 )
• as early as P15 in doxycycline-treated mice
• 27-fold from 10 months of age in doxycycline-treated mice
increased compact bone volume ( J:178340 )
• in doxycycline-treated mice
abnormal trabecular bone morphology ( J:178340 )
• 4.6-fold increase in trabecular bone surface and a smaller bone surface to bone volume in doxycycline-treated mice
increased trabecular bone volume ( J:178340 )
• trabecular, cortical and total volume as early as P15 in doxycycline-treated mice
increased bone trabecula number ( J:178340 )
• 3.6-fold with reduced trabecular separation in doxycycline-treated mice
increased trabecular bone thickness ( J:178340 )
• 8.5-fold in doxycycline-treated mice
osteopetrosis ( J:178340 )
• severe in doxycycline-treated mice
• in mice following adult onset activation with doxycycline
decreased bone resorption ( J:178340 )
• in doxycycline-treated mice

hematopoietic system
abnormal osteoclast differentiation ( J:178340 )
• impaired in doxycycline-treated mice
extramedullary hematopoiesis ( J:178340 )
• in doxycycline-treated mice
decreased bone marrow cell number ( J:178340 )
• at 4 months in doxycycline-treated mice
absent bone marrow cell ( J:178340 )
• at 10 months in doxycycline-treated mice
decreased osteoclast cell number ( J:178340 )
• in doxycycline-treated mice
increased splenocyte number ( J:178340 )
• gradual in doxycycline-treated mice

cellular
abnormal osteoclast differentiation ( J:178340 )
• impaired in doxycycline-treated mice

immune system
abnormal osteoclast differentiation ( J:178340 )
• impaired in doxycycline-treated mice
decreased osteoclast cell number ( J:178340 )
• in doxycycline-treated mice
increased splenocyte number ( J:178340 )
• gradual in doxycycline-treated mice




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
09/30/2025
MGI 6.24 		The Jackson Laboratory